Skip to main content
Premium Trial:

Request an Annual Quote

Catalysis Foundation for Health Taps BioFortis Labmatrix for Tuberculosis Biomarker Study

Premium

This week, BioFortis said that the Catalysis Foundation for Health has selected its Labmatrix database software system to manage an international tuberculosis diagnostic biomarker study funded by the Bill and Melinda Gates Foundation.

Specifically, CFH researchers and their collaborators will use the platform to collect and manage patient specimen data and clinical information, track shipment status, analyze data from thousands of patient biospecimens, and view real-time study results from pre-built or ad hoc data queries.

Furthermore, BioFortis said Labmatrix will improve data quality, consistency, and privacy using its secure project messaging capabilities, standardized electronic case report forms, prescription drug forms, biospecimen and assay result forms, and other workflow-driven information capture mechanisms.

Richard Thayer, CFH's chief executive, said the tool will allow researchers participating in the study to "quickly and securely exchange pertinent information across international sites," thus "facilitating both study data management and patient sample management for this complex tuberculosis diagnostic biomarker project."

CFH is a not-for-profit organization that develops diagnostic tests for resource-poor settings.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.